Clinical Trial Update: Mecobalamin Combined With Ceftriaxone Sodium in the Treatment of Sepsis Liver Injury [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating mecobalamin combined with ceftriaxone sodium for treatment of sepsis with liver dysfunction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Dysfunction
• Sepsis

Drugs mentioned

• Ceftriaxone Sodium (ceftriaxone sodium)
• Mecobalamin (mecobalamin)

Snippet

Sponsor: Sichuan Provincial People's Hospital | Conditions: Sepsis, Liver Dysfunction | Phase 4 | Status: UNKNOWN